Modelling The Costs and Outcomes Associated With Sequence Of Treatment With And Without Tofacitinib For The Treatment of Moderate to Severe Rheumatoid Arthritis In The Us
Abstract
Authors
L. Claxton M. Taylor D. Moynagh D. Gruben G. Wallenstein A. Singh